ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy | University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD | Innovation Grants | 2022 | Wisconsin |
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants | University of Washington, Seattle / Abbye McEwen, MD, PhD | RUNX1 Early Career Investigator Grants | 2022 | Washington |
GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma | Baylor College of Medicine / Kyle Eagen, PhD | R Accelerated Award Grants | 2022 | Texas |
Isoform-specific TNC-redirected T cell Therapy for DIPG | St. Jude Children’s Research Hospital / Stephen Gottschalk, MD and Giedre Krenciute, PhD | Innovation Grants | 2022 | Tennessee |
Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting | Children’s Hospital of Philadelphia / Kristopher Bosse, MD | 'A' Award Grants | 2022 | Pennsylvania |
Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL | Temple University / Christian Hurtz, PhD | 'A' Award Grants | 2022 | Pennsylvania |
Impact of STAG2 loss on DNA Damage and Immunobiology in Ewing sarcoma | University of Pittsburgh / Kelly Bailey, MD, PhD | Innovation Grants | 2022 | Pennsylvania |
Characterizing the Developmental Context of Pediatric Leukemia | Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD | 'A' Award Grants | 2022 | New York |
Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia | Icahn School of Medicine at Mount Sinai / Linda Resar, MD and Jian Jin, PhD | Innovation Grants | 2022 | New York |
Developmental origins of leukemia in Down Syndrome | University of Rochester / James Palis, MD & Laurie Steiner, MD | Innovation Grants | 2022 | New York |